Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 1,330,000 | 1,495,000 | 1,615,000 | 1,368,000 | 1,358,000 |
| Cost of Goods | 1,175,000 | 1,262,000 | 1,337,000 | 1,132,000 | 1,094,000 |
| Gross Profit | 155,000 | 233,000 | 278,000 | 236,000 | 264,000 |
| Operating Expenses | 161,000 | 139,000 | 483,000 | 183,000 | 204,000 |
| Operating Income | -6,000 | 94,000 | -205,000 | 53,000 | 60,000 |
| Interest Expense | 68,000 | 68,000 | 67,000 | 66,000 | 66,000 |
| Other Income | 7,000 | 25,000 | 11,000 | 13,000 | 5,000 |
| Pre-tax Income | -67,000 | 51,000 | -261,000 | 0 | -1,000 |
| Income Tax | -5,000 | -9,000 | 119,000 | 4,000 | 12,000 |
| Net Income Continuous | -62,000 | 60,000 | -380,000 | -4,000 | -13,000 |
| Minority Interests | N/A | N/A | 1,000 | N/A | N/A |
| Net Income | $-61,000 | $60,000 | $-381,000 | $-4,000 | $-13,000 |
| EPS Basic Total Ops | -0.40 | 0.40 | -2.54 | -0.03 | -0.08 |
| EPS Basic Continuous Ops | -0.41 | 0.40 | -2.53 | -0.03 | -0.09 |
| EPS Diluted Total Ops | -0.40 | 0.40 | -2.54 | -0.03 | -0.07 |
| EPS Diluted Continuous Ops | -0.41 | 0.40 | -2.53 | -0.03 | -0.09 |
| EPS Diluted Before Non-Recurring Items | 0.05 | 0.20 | 0.58 | 0.13 | 0.11 |
| EBITDA(a) | $77,000 | $176,000 | $-110,000 | $144,000 | $137,000 |